The correct answer is A. Serum testosterone is at its highest in the early morning. Testosterone levels can occur later in the day in a male with normal testosterone levels (Robertson & Hamlin, 2017: Quallich, 2017).
The correct answer is D. Alpha-feto protein is a testicular cancer tumor marker. It is not checked for sexual dysfunction. TSH, prolactin, and lipids are checked to identify causes of sexual dysfunction (Robertson & Hamlin, 2017: Quallich, 2017).
The correct answer is D. A Complete Blood Count should be obtained every 6 months to follow these patients (Quallich, 2017).
The correct answer is A. Testosterone levels in the therapeutic range will increase energy and morning erections. Answer B is seen in secondary hypogonadism. When treated with testosterone replacement therapy (TRT) testicular size decreases. Prolactin is usually normal in primary hypogonadism. If it is elevated it identifies pituitary dysfunction (Quallich, 2017).
The correct answer is B. Infertility may be irreversible, so testosterone is never to be used for infertility or for a patient desiring to develop a pregnancy. All other answers are inaccurate (Quallich, 2017).
The correct answer is B. Primary hypogonadism is related to testicular failure. The other three answers are related to secondary hypogonadism, which is caused by disorders of the hypothalamus and the pituitary, and luetizing hormone (LH) and follicle stimulating hormone (FSH) would be low with this type of hypogonadism (Quallich, 2017).
The correct answer is C. The medication must remain in the area of the gum and upper incisor for 12 hours to deliver the correct dose. A bitter taste (not a sweet taste) is associated with this medication. There is no restriction on the temperature of fluid ingested (Quallich, 2017).
The correct answer is B. Answers A and C are both older terms used for hypogonadism. Menopause is a term used to describe female hormonal changes (Quallich, 2017).
The correct answer is D. All other answers are incorrect (Quallich, 2017).
Urol Nurs. 2020;40(4):205-206. © 2020 Society of Urologic Nurses and Associates